Israel · Delayed Price · Currency is ILS · Price in ILA Can-Fite BioPharma Statistics
Total Valuation
TLV:CANF has a market cap or net worth of ILS 14.84 million. The enterprise value is -6.00 million.
| Market Cap | 14.84M |
| Enterprise Value | -6.00M |
Important Dates
The next estimated earnings date is Friday, November 27, 2026.
| Earnings Date | Nov 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TLV:CANF has 4.29 million shares outstanding. The number of shares has increased by 196.15% in one year.
| Current Share Class | 4.29M |
| Shares Outstanding | 4.29M |
| Shares Change (YoY) | +196.15% |
| Shares Change (QoQ) | +89.50% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 3.67% |
| Float | 4.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.30 |
| PB Ratio | 1.03 |
| P/TBV Ratio | 1.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.60, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.60 |
| Quick Ratio | 3.17 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.01 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -211.37% and return on invested capital (ROIC) is -132.55%.
| Return on Equity (ROE) | -211.37% |
| Return on Assets (ROA) | -77.12% |
| Return on Invested Capital (ROIC) | -132.55% |
| Return on Capital Employed (ROCE) | -166.93% |
| Weighted Average Cost of Capital (WACC) | 4.02% |
| Revenue Per Employee | 241,307 |
| Profits Per Employee | -5.69M |
| Employee Count | 5 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.62% in the last 52 weeks. The beta is -0.04, so TLV:CANF's price volatility has been lower than the market average.
| Beta (5Y) | -0.04 |
| 52-Week Price Change | -88.62% |
| 50-Day Moving Average | 497.96 |
| 200-Day Moving Average | 929.33 |
| Relative Strength Index (RSI) | 22.91 |
| Average Volume (20 Days) | 30,114 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TLV:CANF had revenue of ILS 1.21 million and -28.46 million in losses. Loss per share was -9.70.
| Revenue | 1.21M |
| Gross Profit | 1.21M |
| Operating Income | -28.99M |
| Pretax Income | -28.46M |
| Net Income | -28.46M |
| EBITDA | -28.99M |
| EBIT | -28.99M |
| Loss Per Share | -9.70 |
Balance Sheet
The company has 20.98 million in cash and 145,976 in debt, with a net cash position of 20.84 million or 4.86 per share.
| Cash & Cash Equivalents | 20.98M |
| Total Debt | 145,976 |
| Net Cash | 20.84M |
| Net Cash Per Share | 4.86 |
| Equity (Book Value) | 14.46M |
| Book Value Per Share | 3.38 |
| Working Capital | 17.21M |
Cash Flow
In the last 12 months, operating cash flow was -28.33 million and capital expenditures -5,958, giving a free cash flow of -28.34 million.
| Operating Cash Flow | -28.33M |
| Capital Expenditures | -5,958 |
| Depreciation & Amortization | 6,063 |
| Net Borrowing | n/a |
| Free Cash Flow | -28.34M |
| FCF Per Share | -6.61 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -2,402.96% |
| Pretax Margin | -2,358.76% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TLV:CANF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -196.15% |
| Shareholder Yield | -196.15% |
| Earnings Yield | -191.78% |
| FCF Yield | -190.98% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 5, 2026. It was a reverse split with a ratio of 0.0003333333.
| Last Split Date | Jan 5, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.0003333333 |
Scores
TLV:CANF has an Altman Z-Score of -32.41 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -32.41 |
| Piotroski F-Score | 2 |